-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O1JzVbtTy2WXEvmCiH+yCvtk2TExpZK/v+Sci1Nh1E6IRa3ob0glFgl2HU75Odwy 0AbRPyckforIMENpIGTGBw== 0001179110-10-016256.txt : 20101118 0001179110-10-016256.hdr.sgml : 20101118 20101118090421 ACCESSION NUMBER: 0001179110-10-016256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101116 FILED AS OF DATE: 20101118 DATE AS OF CHANGE: 20101118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VILLAFRANCA JOSEPH J CENTRAL INDEX KEY: 0001196841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 101201446 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOGEN INC CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 4 1 edgar.xml FORM 4 - X0303 4 2010-11-16 0 0000855654 IMMUNOGEN INC IMGN 0001196841 VILLAFRANCA JOSEPH J 1679 LOOKAWAY COURT NEWHOPE PA 18938 1 0 0 0 Deferred Share Unit 0 2010-11-17 4 A 0 3836 0 A 2011-02-01 Common Stock 3836 3836 D Stock option (right to buy) 7.82 2010-11-16 4 A 0 6211 7.82 A 2011-02-01 2020-11-16 Common Stock 6211 6211 D The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis. The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors. The deferred share units vest ratably over a one year period in quarterly increments beginning on February 1, 2011, contingent upon the individual remaining a director as of each vesting date. Exercisable as to 1553 shares commencing on February 1, 2011, 1553 shares commencing on May 1, 2011, 1552 shares commencing on August 1, 2011 and 1553 shares commencing on November 1, 2011 /s/ Craig Barrows, attorney in fact 2010-11-17 -----END PRIVACY-ENHANCED MESSAGE-----